U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 133

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr19:17783275
GRCh38:
Chr19:17672466
UNC13AT61MAmyotrophic lateral sclerosisassociation
(Mar 22, 2023)
no assertion criteria provided
2.
GRCh37:
Chr19:1041971
GRCh38:
Chr19:1041972
ABCA7L101RAmyotrophic lateral sclerosisUncertain significance
(Nov 10, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr2:202631985
GRCh38:
Chr2:201767262
ALS2L48VAmyotrophic lateral sclerosisLikely pathogenic
(Jul 1, 2022)
no assertion criteria provided
4.
GRCh37:
Chr22:29879817-29879852
GRCh38:
Chr22:29483828-29483863
NEFHAmyotrophic lateral sclerosisUncertain significanceno assertion criteria provided
5.
GRCh37:
Chr5:179260046
GRCh38:
Chr5:179833046
SQSTM1I173V, I257VInborn genetic diseases, Frontotemporal dementia and/or amyotrophic lateral sclerosis 1, Paget disease of bone 2, early-onset
Uncertain significance
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr22:29884950
GRCh38:
Chr22:29488961
NEFHE441KInborn genetic diseases, not providedConflicting interpretations of pathogenicity
(Oct 23, 2022)
criteria provided, conflicting interpretations
7.
GRCh37:
Chr10:81915646
GRCh38:
Chr10:80155890
ANXA11R461Q, R494QAmyotrophic lateral sclerosis, not providedUncertain significance
(Jul 11, 2022)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr10:81928790-81928792
GRCh38:
Chr10:80169034-80169036
ANXA11Q132del, Q165delAmyotrophic lateral sclerosisUncertain significance
(Jan 1, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr10:81926643
GRCh38:
Chr10:80166887
ANXA11Amyotrophic lateral sclerosis, not providedUncertain significance
(Jun 2, 2022)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr21:33040876
GRCh38:
Chr21:31668563
SOD1I150MAmyotrophic lateral sclerosisLikely pathogenic
(Jan 1, 2022)
criteria provided, single submitter
11.
GRCh38:
Chr9:27573529-27573534
C9orf72, LOC109504728, LOC129929032Amyotrophic lateral sclerosisUncertain significance
(Jan 1, 2022)
criteria provided, single submitter
12.
GRCh38:
Chr9:27573529-27573534
C9orf72, LOC109504728, LOC129929032Amyotrophic lateral sclerosisPathogenic
(Jan 1, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr2:220115207
GRCh38:
Chr2:219250485
TUBA4AV390G, V405GAmyotrophic lateral sclerosisUncertain significance
(Jan 1, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr9:135145054
GRCh38:
Chr9:132269667
LOC126860782, SETXI2412TAmyotrophic lateral sclerosisUncertain significance
(Jan 1, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr9:135147089
GRCh38:
Chr9:132271702
SETXAmyotrophic lateral sclerosisUncertain significance
(Jan 1, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr9:135203720
GRCh38:
Chr9:132328333
SETXV1089MAmyotrophic lateral sclerosisUncertain significance
(Jan 1, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr9:135205051
GRCh38:
Chr9:132329664
SETXF645YAmyotrophic lateral sclerosisUncertain significance
(Jan 1, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr9:135205587
GRCh38:
Chr9:132330200
SETXI466MAmyotrophic lateral sclerosisUncertain significance
(Jan 1, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr17:4851604
GRCh38:
Chr17:4948309
PFN1P29LAmyotrophic lateral sclerosis, not providedUncertain significance
(Feb 8, 2022)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr10:13154530
GRCh38:
Chr10:13112530
OPTNR149SAmyotrophic lateral sclerosisUncertain significance
(Jan 1, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr5:138661301
GRCh38:
Chr5:139325612
MATR3T436I, T486I, T774IAmyotrophic lateral sclerosisUncertain significance
(Jan 1, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr5:138643730
GRCh38:
Chr5:139308041
MATR3Q209RAmyotrophic lateral sclerosisUncertain significance
(Jan 1, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr3:52728869
GRCh38:
Chr3:52694853
GLT8D1I370VAmyotrophic lateral sclerosisUncertain significance
(Jan 1, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr9:131296049
GRCh38:
Chr9:128533770
GLE1, LOC101929270E489KAmyotrophic lateral sclerosisUncertain significance
(Jan 1, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr6:110048443
GRCh38:
Chr6:109727240
FIG4R141WCharcot-Marie-Tooth disease type 4, Amyotrophic lateral sclerosis, Inborn genetic diseases
Uncertain significance
(Sep 13, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr2:212251722
GRCh38:
Chr2:211386997
ERBB4K1097E, K1113EAmyotrophic lateral sclerosisUncertain significance
(Jan 1, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr12:109278816
GRCh38:
Chr12:108885040
DAOG12RAmyotrophic lateral sclerosisUncertain significance
(Jan 1, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr16:2506578
GRCh38:
Chr16:2456577
CCNF, LOC105371050V332M, V640MAmyotrophic lateral sclerosisUncertain significance
(Jan 1, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr16:2487202
GRCh38:
Chr16:2437201
CCNFR140QAmyotrophic lateral sclerosis, Inborn genetic diseasesUncertain significance
(Jan 1, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr14:102467322
GRCh38:
Chr14:102000985
DYNC1H1Q1369RAmyotrophic lateral sclerosisUncertain significance
(Aug 7, 2021)
no assertion criteria provided
31.
GRCh37:
Chr2:202588052
GRCh38:
Chr2:201723329
ALS2Infantile-onset ascending hereditary spastic paralysisLikely pathogenic
(Aug 28, 2021)
criteria provided, single submitter
32.
GRCh37:
Chr6:110048444
GRCh38:
Chr6:109727241
FIG4R141QCharcot-Marie-Tooth disease type 4, Amyotrophic lateral sclerosisUncertain significance
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr9:94874779-94874784
GRCh38:
Chr9:92112497-92112502
SPTLC1Amyotrophic lateral sclerosisLikely pathogeniccriteria provided, single submitter
34.
GRCh37:
Chr19:17735631
GRCh38:
Chr19:17624822
UNC13AAmyotrophic lateral sclerosisUncertain significance
(Sep 9, 2020)
criteria provided, single submitter
35.
GRCh37:
Chr20:60747782
GRCh38:
Chr20:62172726
SS18L1A190T, A321TAmyotrophic lateral sclerosis, not providedConflicting interpretations of pathogenicity
(May 4, 2021)
criteria provided, conflicting interpretations
36.
GRCh37:
Chr9:135203938
GRCh38:
Chr9:132328551
SETXI1016TInborn genetic diseases, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2,
Amyotrophic lateral sclerosis type 4
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr5:150436517
GRCh38:
Chr5:151056956
TNIP1A146V, A93VAmyotrophic lateral sclerosisUncertain significance
(Sep 9, 2020)
criteria provided, single submitter
38.
GRCh37:
Chr9:135204560
GRCh38:
Chr9:132329173
SETXI809VAmyotrophic lateral sclerosisUncertain significance
(Sep 9, 2020)
criteria provided, single submitter
39.
GRCh37:
Chr14:31164033
GRCh38:
Chr14:30694827
SCFD1T248A, T341A, T366A, T374A, T433AAmyotrophic lateral sclerosisUncertain significance
(Sep 9, 2020)
criteria provided, single submitter
40.
GRCh37:
Chr17:26712165
GRCh38:
Chr17:28385146
SARM1Y501HAmyotrophic lateral sclerosisUncertain significance
(Sep 9, 2020)
criteria provided, single submitter
41.
GRCh37:
Chr4:170523675
GRCh38:
Chr4:169602524
NEK1N36SAmyotrophic lateral sclerosisUncertain significance
(Sep 9, 2020)
criteria provided, single submitter
42.
GRCh37:
Chr22:29885638
GRCh38:
Chr22:29489649
NEFHV670EInborn genetic diseases, Amyotrophic lateral sclerosis, not provided
Conflicting interpretations of pathogenicity
(Jan 31, 2022)
criteria provided, conflicting interpretations
43.
GRCh37:
Chr3:39544333
GRCh38:
Chr3:39502842
MOBPR172S, R196SAmyotrophic lateral sclerosisUncertain significance
(Sep 9, 2020)
criteria provided, single submitter
44.
GRCh37:
Chr22:29693915
GRCh38:
Chr22:29297925
EWSR1G409S, G464S, G465S, G470Snot provided, Amyotrophic lateral sclerosisConflicting interpretations of pathogenicity
(Jun 1, 2023)
criteria provided, conflicting interpretations
45.
GRCh37:
Chr22:29695693
GRCh38:
Chr22:29299703
EWSR1D539N, D594N, D595N, D600NAmyotrophic lateral sclerosisUncertain significance
(Sep 9, 2020)
criteria provided, single submitter
46.
GRCh37:
Chr2:212252677
GRCh38:
Chr2:211387952
ERBB4M1059TAmyotrophic lateral sclerosisUncertain significance
(Sep 9, 2020)
criteria provided, single submitter
47.
GRCh37:
Chr17:40149254
GRCh38:
Chr17:41997236
DNAJC7M1T, M57TAmyotrophic lateral sclerosisUncertain significance
(Sep 9, 2020)
criteria provided, single submitter
48.
GRCh37:
Chr1:112309283
GRCh38:
Chr1:111766661
DDX20L746SAmyotrophic lateral sclerosisUncertain significance
(Sep 9, 2020)
criteria provided, single submitter
49.
GRCh37:
Chr21:45750684
GRCh38:
Chr21:44330801
CFAP410A221TAmyotrophic lateral sclerosisUncertain significance
(Sep 9, 2020)
criteria provided, single submitter
50.
GRCh37:
Chr12:111923123
GRCh38:
Chr12:111485319
ATXN2I695L, I719L, I824LAmyotrophic lateral sclerosisUncertain significance
(Sep 9, 2020)
criteria provided, single submitter
51.
GRCh37:
Chr12:109281281
GRCh38:
Chr12:108887505
DAOA84TDAO-related condition, Amyotrophic lateral sclerosisConflicting interpretations of pathogenicity
(Dec 13, 2022)
criteria provided, conflicting interpretations
52.
GRCh37:
Chr2:74595249
GRCh38:
Chr2:74368122
DCTN1I488F, I585F, I599F, I602F, I605F, I615F, I622FAmyotrophic lateral sclerosisLikely pathogenic
(Jul 31, 2020)
criteria provided, single submitter
53.
GRCh37:
Chr2:212248453
GRCh38:
Chr2:211383728
ERBB4G1256R, G1272RAmyotrophic lateral sclerosisLikely pathogenic
(Jul 31, 2020)
criteria provided, single submitter
54.
GRCh37:
Chr14:31099759
GRCh38:
Chr14:30630553
SCFD1I3T, I70TAmyotrophic lateral sclerosisUncertain significance
(Jul 31, 2020)
criteria provided, single submitter
55.
GRCh37:
Chr12:112036782-112036783
GRCh38:
Chr12:111598978-111598979
ATXN2, LOC130008791Amyotrophic lateral sclerosisrisk factor
(Jul 31, 2020)
criteria provided, single submitter
56.
GRCh37:
Chr15:23086364-23086365
GRCh38:
Chr15:22786677-22786678
LOC130056709, NIPA1Amyotrophic lateral sclerosisrisk factor
(Jul 31, 2020)
criteria provided, single submitter
57.
GRCh37:
Chr15:44949373
GRCh38:
Chr15:44657175
SPG11Charcot-Marie-Tooth disease axonal type 2X, Amyotrophic lateral sclerosis, Amyotrophic lateral sclerosis type 5,
Hereditary spastic paraplegia 11
Conflicting interpretations of pathogenicity
(Jul 18, 2022)
criteria provided, conflicting interpretations
58.
GRCh37:
Chr2:202606527
GRCh38:
Chr2:201741804
ALS2R741*Infantile-onset ascending hereditary spastic paralysisPathogenic
(Aug 25, 2019)
criteria provided, single submitter
59.
GRCh37:
Chr21:33031996
GRCh38:
Chr21:31659683
SOD1, SOD1-DTAmyotrophic lateral sclerosis, Amyotrophic lateral sclerosis type 1Uncertain significance
(Jan 1, 2022)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr15:44925820
GRCh38:
Chr15:44633622
SPG11R540CAmyotrophic lateral sclerosis, Inborn genetic diseases, Amyotrophic lateral sclerosis type 5,
Charcot-Marie-Tooth disease axonal type 2X, Hereditary spastic paraplegia 11
Uncertain significance
(Sep 12, 2022)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr15:78913136
GRCh38:
Chr15:78620794
CHRNA3M1VAmyotrophic lateral sclerosisLikely pathogenic
(Mar 31, 2020)
criteria provided, single submitter
62.
GRCh37:
Chr15:78910978-78910979
GRCh38:
Chr15:78618636-78618637
CHRNA3T83fsAmyotrophic lateral sclerosisLikely pathogenic
(Mar 31, 2020)
criteria provided, single submitter
63.
GRCh37:
Chr15:78894275-78894276
GRCh38:
Chr15:78601933-78601934
CHRNA3I237fsAmyotrophic lateral sclerosisLikely pathogenic
(Mar 31, 2020)
criteria provided, single submitter
64.
GRCh37:
Chr15:78894259
GRCh38:
Chr15:78601917
CHRNA3L242fsAmyotrophic lateral sclerosisLikely pathogenic
(Mar 31, 2020)
criteria provided, single submitter
65.
GRCh37:
Chr15:78894232
GRCh38:
Chr15:78601890
CHRNA3P251RAmyotrophic lateral sclerosisUncertain significance
(Mar 31, 2020)
criteria provided, single submitter
66.
GRCh37:
Chr12:49689173
GRCh38:
Chr12:49295390
PRPH, TROAP-AS1R64*Amyotrophic lateral sclerosisUncertain significance
(Mar 31, 2020)
criteria provided, single submitter
67.
GRCh37:
Chr7:94935670
GRCh38:
Chr7:95306358
PON1Y236CAmyotrophic lateral sclerosisUncertain significance
(Mar 31, 2020)
criteria provided, single submitter
68.
GRCh37:
Chr19:7620584
GRCh38:
Chr19:7555698
PNPLA6G1010R, G972R, G1020R, G945RAmyotrophic lateral sclerosis, Hereditary spastic paraplegia 39Uncertain significance
(Jun 8, 2022)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr19:7605129
GRCh38:
Chr19:7540243
PNPLA6G178C, G217C, G226CAmyotrophic lateral sclerosisUncertain significance
(Mar 31, 2020)
criteria provided, single submitter
70.
GRCh37:
Chr6:110086229
GRCh38:
Chr6:109765026
FIG4R483Qnot provided, Amyotrophic lateral sclerosisConflicting interpretations of pathogenicity
(Jun 19, 2020)
criteria provided, conflicting interpretations
71.
GRCh37:
Chr8:28017873
GRCh38:
Chr8:28160356
ELP3R343H, R370H, R448H, R390H, R462HAmyotrophic lateral sclerosisUncertain significance
(Mar 31, 2020)
criteria provided, single submitter
72.
GRCh37:
Chr2:74605312
GRCh38:
Chr2:74378185
DCTN1R15C, R32CAmyotrophic lateral sclerosis type 1, Perry syndrome, Neuronopathy, distal hereditary motor, type 7B,
Amyotrophic lateral sclerosis
Conflicting interpretations of pathogenicity
(Sep 1, 2021)
criteria provided, conflicting interpretations
73.
GRCh37:
Chr2:74594495
GRCh38:
Chr2:74367368
DCTN1L709P, L726P, L739P, L612P, L746P, L723P, L729PAmyotrophic lateral sclerosisUncertain significance
(Mar 31, 2020)
criteria provided, single submitter
74.
GRCh37:
Chr2:74594488
GRCh38:
Chr2:74367361
DCTN1D711E, D728E, D614E, D741E, D748E, D725E, D731EPerry syndrome, Neuronopathy, distal hereditary motor, type 7B, Amyotrophic lateral sclerosis type 1,
not provided, Amyotrophic lateral sclerosis
Uncertain significance
(Jul 1, 2022)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr2:74593112
GRCh38:
Chr2:74365985
DCTN1R798C, R912C, R895C, R925C, R932C, R915C, R909CPerry syndrome, Neuronopathy, distal hereditary motor, type 7B, Amyotrophic lateral sclerosis type 1,
DCTN1-related condition, Amyotrophic lateral sclerosis
Conflicting interpretations of pathogenicity
(Aug 1, 2023)
criteria provided, conflicting interpretations
76.
GRCh37:
Chr12:109294229
GRCh38:
Chr12:108900453
DAOG321EAmyotrophic lateral sclerosisUncertain significance
(Mar 31, 2020)
criteria provided, single submitter
77.
GRCh37:
Chr12:109281243
GRCh38:
Chr12:108887467
DAOT71IAmyotrophic lateral sclerosisUncertain significance
(Mar 31, 2020)
criteria provided, single submitter
78.
GRCh37:
Chr12:109278828
GRCh38:
Chr12:108885052
DAOA16TDAO-related condition, Amyotrophic lateral sclerosisConflicting interpretations of pathogenicity
(Feb 7, 2023)
criteria provided, conflicting interpretations
79.
GRCh37:
Chr17:4851653
GRCh38:
Chr17:4948358
PFN1A13TAmyotrophic lateral sclerosisUncertain significance
(Mar 31, 2020)
criteria provided, single submitter
80.
GRCh37:
Chr4:170428877
GRCh38:
Chr4:169507726
NEK1E562*, E634*, E564*, E590*, E606*, E537*, E589*Amyotrophic lateral sclerosisUncertain significance
(Mar 31, 2020)
criteria provided, single submitter
81.
GRCh37:
Chr9:135163699
GRCh38:
Chr9:132288312
SETXR2083IAmyotrophic lateral sclerosis type 4, Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2, Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2,
Amyotrophic lateral sclerosis type 4, not provided, Amyotrophic lateral sclerosis
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
82.
GRCh37:
Chr14:21162046-21162047
GRCh38:
Chr14:20693887-20693888
ANG, EGILA, RNASE4G109fsAmyotrophic lateral sclerosisUncertain significance
(Mar 31, 2020)
criteria provided, single submitter
83.
GRCh37:
Chr2:212812268
GRCh38:
Chr2:211947543
ERBB4R103Hnot provided, ERBB4-related condition, Amyotrophic lateral sclerosis
Conflicting interpretations of pathogenicity
(Oct 19, 2022)
criteria provided, conflicting interpretations
84.
GRCh37:
Chr2:212589887
GRCh38:
Chr2:211725162
ERBB4G219SAmyotrophic lateral sclerosisUncertain significance
(Mar 31, 2020)
criteria provided, single submitter
85.
GRCh37:
Chr2:212989553
GRCh38:
Chr2:212124828
ERBB4Y53CAmyotrophic lateral sclerosisUncertain significance
(Mar 31, 2020)
criteria provided, single submitter
86.
GRCh37:
Chr2:212295795
GRCh38:
Chr2:211431070
ERBB4V840IAmyotrophic lateral sclerosisUncertain significance
(Mar 31, 2020)
criteria provided, single submitter
87.
GRCh37:
Chr15:78927869
GRCh38:
Chr15:78635527
CHRNB4R39LAmyotrophic lateral sclerosisUncertain significance
(Mar 31, 2020)
criteria provided, single submitter
88.
GRCh37:
Chr15:78922149
GRCh38:
Chr15:78629807
CHRNB4N166KAmyotrophic lateral sclerosisBenign
(Mar 31, 2020)
criteria provided, single submitter
89.
GRCh37:
Chr15:78921343
GRCh38:
Chr15:78629001
CHRNB4A435VAmyotrophic lateral sclerosisBenign
(Mar 31, 2020)
criteria provided, single submitter
90.
GRCh37:
Chr20:61982107
GRCh38:
Chr20:63350755
CHRNA4N219T, N43TAmyotrophic lateral sclerosisUncertain significance
(Mar 31, 2020)
criteria provided, single submitter
91.
GRCh37:
Chr9:94812271
GRCh38:
Chr9:92049989
SPTLC1R132*, R287*, R165*not provided, Amyotrophic lateral sclerosis, Hereditary sensory and autonomic neuropathy type 1
Uncertain significance
(Jan 1, 2022)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr10:13175499
GRCh38:
Chr10:13133499
OPTNAmyotrophic lateral sclerosis type 12, Glaucoma 1, open angle, E, Primary open angle glaucoma,
not provided, Amyotrophic lateral sclerosis, Inborn genetic diseases
Uncertain significance
(Jan 21, 2022)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr20:61981784
GRCh38:
Chr20:63350432
CHRNA4V151M, V327MAutosomal dominant nocturnal frontal lobe epilepsy, Amyotrophic lateral sclerosisConflicting interpretations of pathogenicity
(Dec 23, 2021)
criteria provided, conflicting interpretations
94.
GRCh37:
Chr12:64875802
GRCh38:
Chr12:64482022
TBK1Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8, Amyotrophic lateral sclerosis, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4
Pathogenic
(Oct 5, 2023)
criteria provided, multiple submitters, no conflicts
95.
GRCh37:
Chr12:64891001-64891003
GRCh38:
Chr12:64497221-64497223
TBK1E643delTBK1-related condition, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, not provided,
Amyotrophic lateral sclerosis
Pathogenic/Likely pathogenic
(May 25, 2023)
criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr2:212576777
GRCh38:
Chr2:211712052
ERBB4H374QAmyotrophic lateral sclerosis, not provided, Amyotrophic lateral sclerosis type 19
Conflicting interpretations of pathogenicity
(Dec 1, 2022)
criteria provided, conflicting interpretations
97.
GRCh37:
Chr2:31414830
GRCh38:
Chr2:31191964
CAPN14L417F, L241Fnot provided, Amyotrophic lateral sclerosisConflicting interpretations of pathogenicity
(Sep 9, 2020)
criteria provided, conflicting interpretations
98.
GRCh37:
Chr21:33039648
GRCh38:
Chr21:31667335
SOD1S106LAmyotrophic lateral sclerosis, Amyotrophic lateral sclerosis type 1Pathogenic
(Oct 14, 2021)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr12:64868171
GRCh38:
Chr12:64474391
TBK1Amyotrophic lateral sclerosis, TBK1-related condition, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4
Pathogenic/Likely pathogenic
(Dec 8, 2022)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr5:179251221
GRCh38:
Chr5:179824221
SQSTM1G191R, G107RFrontotemporal dementia and/or amyotrophic lateral sclerosis 1, Paget disease of bone 2, early-onset, Amyotrophic lateral sclerosis
Uncertain significance
(Jul 5, 2022)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination